Altimmune Total Assets vs Net Income Analysis

ALT Stock  USD 8.89  0.24  2.77%   
Altimmune financial indicator trend analysis is way more than just evaluating Altimmune prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Altimmune is a good investment. Please check the relationship between Altimmune Total Assets and its Net Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.

Total Assets vs Net Income

Total Assets vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Altimmune Total Assets account and Net Income. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Altimmune's Total Assets and Net Income is -0.14. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Net Income in the same time period over historical financial statements of Altimmune, assuming nothing else is changed. The correlation between historical values of Altimmune's Total Assets and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Altimmune are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Total Assets i.e., Altimmune's Total Assets and Net Income go up and down completely randomly.

Correlation Coefficient

-0.14
Relationship DirectionNegative 
Relationship StrengthInsignificant

Total Assets

Total assets refers to the total amount of Altimmune assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Altimmune books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Altimmune financial statement analysis. It represents the amount of money remaining after all of Altimmune operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most indicators from Altimmune's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Altimmune current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.Tax Provision is likely to gain to 0.00 in 2024, whereas Selling General Administrative is likely to drop slightly above 13.5 M in 2024.
 2021 2022 2023 2024 (projected)
Research Development74.5M70.5M68.1M71.5M
Depreciation And Amortization11.2M2.8M3.3M3.4M

Altimmune fundamental ratios Correlations

0.390.420.86-0.89-0.390.640.930.980.080.810.340.690.440.990.160.68-0.120.02-0.27-0.190.050.210.580.020.84
0.391.0-0.13-0.480.35-0.020.450.440.4-0.11-0.08-0.251.00.420.38-0.11-0.1-0.290.24-0.13-0.22-0.220.93-0.280.33
0.421.0-0.1-0.520.310.020.490.480.41-0.07-0.03-0.211.00.450.4-0.06-0.12-0.310.25-0.15-0.23-0.220.94-0.280.34
0.86-0.13-0.1-0.69-0.60.690.750.81-0.140.930.390.87-0.080.84-0.040.78-0.060.18-0.43-0.120.190.340.110.170.73
-0.89-0.48-0.52-0.690.37-0.46-0.98-0.91-0.25-0.66-0.61-0.55-0.53-0.9-0.3-0.590.250.270.130.30.12-0.07-0.690.03-0.58
-0.390.350.31-0.60.37-0.79-0.44-0.45-0.34-0.76-0.24-0.890.3-0.39-0.44-0.790.490.380.00.470.380.060.150.22-0.31
0.64-0.020.020.69-0.46-0.790.580.650.20.870.020.880.030.630.320.92-0.24-0.12-0.01-0.24-0.150.030.2-0.270.6
0.930.450.490.75-0.98-0.440.580.950.250.740.550.640.50.940.310.69-0.26-0.26-0.15-0.31-0.120.080.67-0.070.64
0.980.440.480.81-0.91-0.450.650.950.220.790.320.70.490.990.30.67-0.26-0.15-0.17-0.31-0.10.10.61-0.070.84
0.080.40.41-0.14-0.25-0.340.20.250.22-0.02-0.010.130.40.140.980.09-0.42-0.650.5-0.36-0.61-0.620.34-0.370.0
0.81-0.11-0.070.93-0.66-0.760.870.740.79-0.020.330.95-0.050.790.10.93-0.2-0.01-0.33-0.250.020.240.17-0.110.68
0.34-0.08-0.030.39-0.61-0.240.020.550.32-0.010.330.28-0.040.33-0.040.35-0.08-0.18-0.14-0.080.050.120.170.19-0.16
0.69-0.25-0.210.87-0.55-0.890.880.640.70.130.950.28-0.190.680.240.91-0.31-0.12-0.23-0.33-0.120.13-0.01-0.10.6
0.441.01.0-0.08-0.530.30.030.50.490.4-0.05-0.04-0.190.470.39-0.05-0.14-0.290.24-0.17-0.24-0.180.94-0.260.36
0.990.420.450.84-0.9-0.390.630.940.990.140.790.330.680.470.210.67-0.09-0.02-0.22-0.160.060.120.6-0.020.84
0.160.380.4-0.04-0.3-0.440.320.310.30.980.1-0.040.240.390.210.21-0.42-0.630.46-0.38-0.6-0.570.35-0.40.09
0.68-0.11-0.060.78-0.59-0.790.920.690.670.090.930.350.91-0.050.670.21-0.16-0.1-0.19-0.19-0.030.140.21-0.240.47
-0.12-0.1-0.12-0.060.250.49-0.24-0.26-0.26-0.42-0.2-0.08-0.31-0.14-0.09-0.42-0.160.7-0.230.980.93-0.08-0.080.07-0.14
0.02-0.29-0.310.180.270.38-0.12-0.26-0.15-0.65-0.01-0.18-0.12-0.29-0.02-0.63-0.10.7-0.370.650.750.52-0.270.490.08
-0.270.240.25-0.430.130.0-0.01-0.15-0.170.5-0.33-0.14-0.230.24-0.220.46-0.19-0.23-0.37-0.05-0.38-0.570.10.04-0.26
-0.19-0.13-0.15-0.120.30.47-0.24-0.31-0.31-0.36-0.25-0.08-0.33-0.17-0.16-0.38-0.190.980.65-0.050.9-0.2-0.130.11-0.21
0.05-0.22-0.230.190.120.38-0.15-0.12-0.1-0.610.020.05-0.12-0.240.06-0.6-0.030.930.75-0.380.90.06-0.150.170.04
0.21-0.22-0.220.34-0.070.060.030.080.1-0.620.240.120.13-0.180.12-0.570.14-0.080.52-0.57-0.20.06-0.090.460.15
0.580.930.940.11-0.690.150.20.670.610.340.170.17-0.010.940.60.350.21-0.08-0.270.1-0.13-0.15-0.09-0.320.38
0.02-0.28-0.280.170.030.22-0.27-0.07-0.07-0.37-0.110.19-0.1-0.26-0.02-0.4-0.240.070.490.040.110.170.46-0.32-0.02
0.840.330.340.73-0.58-0.310.60.640.840.00.68-0.160.60.360.840.090.47-0.140.08-0.26-0.210.040.150.38-0.02
Click cells to compare fundamentals

Altimmune Account Relationship Matchups

Altimmune fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets54.1M245.1M218.9M206.9M238.0M249.9M
Other Current Liab3.6M11.0M6.1M11.8M13.6M17.4M
Total Current Liabilities3.9M12.0M18.3M17.1M19.6M21.6M
Total Stockholder Equity45.5M225.9M199.1M185.3M213.1M223.7M
Net Debt(7.2M)(114.1M)(188.8M)(110.0M)(99.0M)(94.0M)
Retained Earnings(137.4M)(186.4M)(293.2M)(377.9M)(340.1M)(323.1M)
Accounts Payable18.2K612.3K2.0M4.8M5.5M5.8M
Cash9.0M115.9M190.3M111.1M127.8M134.1M
Cash And Short Term Investments37.2M215.9M190.3M184.9M212.6M223.2M
Common Stock Total Equity876.01.5K3.7K4.1K4.7K3.9K
Common Stock Shares Outstanding13.1M25.6M41.3M46.9M54.0M56.7M
Liabilities And Stockholders Equity54.1M245.1M218.9M206.9M238.0M249.9M
Other Current Assets504.4M2.0B13.4B5.4M6.2M5.9M
Other Stockholder Equity187.9M417.3M497.3M568.4M653.7M686.3M
Total Liab8.5M19.2M19.7M21.6M24.9M27.8M
Total Current Assets39.4M230.3M204.1M192.8M221.7M232.8M
Common Stock1.5K3.7K4.1K5K5.8K4.0K
Other Assets128.5K977.2K73.8K19K17.1K16.2K
Non Current Liabilities Total4.6M7.2M1.5M4.6M4.1M4.8M
Short Term Debt259.4K356.7K411.5K452K406.8K386.5K
Short Long Term Debt Total1.7M1.8M1.5M1.1M1.0M961.0K
Property Plant And Equipment Net1.8M2.0M1.4M1.1M972.9K1.5M
Non Current Assets Total14.7M14.9M14.7M14.1M16.2M11.1M
Non Currrent Assets Other128.5K73.4K872.0K615K707.3K486.6K
Net Receivables1.7M12.4M5.8M2.5M2.3M2.2M
Property Plant And Equipment Gross1.8M2.0M1.4M2.6M2.3M1.6M
Accumulated Other Comprehensive Income(5.0M)(5.0M)(5.0M)(5.2M)(4.7M)(4.5M)
Intangible Assets12.7M12.8M12.4M12.4M14.3M11.8M
Net Tangible Assets32.8M213.1M186.7M172.9M198.8M208.7M
Long Term Debt1.9M1.9M1.8M1.5M1.7M1.5M
Retained Earnings Total Equity(116.9M)(137.4M)(186.4M)(293.2M)(337.1M)(354.0M)
Capital Surpluse170.2M187.9M417.3M497.3M571.9M600.5M
Property Plant Equipment1.1M1.1M1.4M1.7M1.9M2.0M
Long Term Debt Total1.9M1.9M1.8M1.5M1.7M2.0M
Non Current Liabilities Other2.8M5.4M1.5M3.9M4.5M4.7M
Other Liab3.1M7.2M330.5K3.9M4.5M3.3M

Pair Trading with Altimmune

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Altimmune position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altimmune will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Altimmune could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Altimmune when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Altimmune - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Altimmune to buy it.
The correlation of Altimmune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Altimmune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Altimmune moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Altimmune can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Altimmune is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Altimmune Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Altimmune Stock. Highlighted below are key reports to facilitate an investment decision about Altimmune Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Altimmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Altimmune Stock please use our How to Invest in Altimmune guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Altimmune Stock analysis

When running Altimmune's price analysis, check to measure Altimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Altimmune is operating at the current time. Most of Altimmune's value examination focuses on studying past and present price action to predict the probability of Altimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Altimmune's price. Additionally, you may evaluate how the addition of Altimmune to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stocks Directory
Find actively traded stocks across global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Is Altimmune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Altimmune. If investors know Altimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Altimmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.54)
Revenue Per Share
0.005
Quarterly Revenue Growth
180
Return On Assets
(0.27)
Return On Equity
(0.44)
The market value of Altimmune is measured differently than its book value, which is the value of Altimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Altimmune's value that differs from its market value or its book value, called intrinsic value, which is Altimmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Altimmune's market value can be influenced by many factors that don't directly affect Altimmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Altimmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Altimmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Altimmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.